181 related articles for article (PubMed ID: 12152986)
21. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
[TBL] [Abstract][Full Text] [Related]
22. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.
Arico M; Imashuku S; Clementi R; Hibi S; Teramura T; Danesino C; Haber DA; Nichols KE
Blood; 2001 Feb; 97(4):1131-3. PubMed ID: 11159547
[TBL] [Abstract][Full Text] [Related]
23. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
[TBL] [Abstract][Full Text] [Related]
25. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
[TBL] [Abstract][Full Text] [Related]
26. Immunology. Sinking surveillance's flagship.
Klein G; Klein E
Nature; 1998 Oct; 395(6701):441, 443-4. PubMed ID: 9774094
[No Abstract] [Full Text] [Related]
27. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M
Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488
[TBL] [Abstract][Full Text] [Related]
28. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
[TBL] [Abstract][Full Text] [Related]
29. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
30. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
31. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
[No Abstract] [Full Text] [Related]
32. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
33. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
[TBL] [Abstract][Full Text] [Related]
34. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
[TBL] [Abstract][Full Text] [Related]
36. The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL
Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
[TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease.
Moretta A; Bottino C; Parolini S; Moretta L; Biassoni R; Notarangelo LD
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):513-7. PubMed ID: 11964734
[TBL] [Abstract][Full Text] [Related]
38. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
Kis LL; Nagy N; Klein G; Klein E
Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
[TBL] [Abstract][Full Text] [Related]
39. SAP: a molecular switch regulating the immune response through a unique signaling mechanism.
Veillette A
Eur J Immunol; 2003 May; 33(5):1141-4. PubMed ID: 12731038
[No Abstract] [Full Text] [Related]
40. Absence of SLAM mutations in EBV-associated lymphoproliferative disease patients.
Ferrand V; Li C; Romeo G; Yin L
J Med Virol; 2003 May; 70(1):131-6. PubMed ID: 12629654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
